Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Completed 4Not yet recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Peripheral Nervous System Diseases 3Pain 3Neurotoxicity Syndromes 1Neoplasms 1Cancer Pain 1Acute Pain 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 165Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 83Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Duloxetine Hydrochloride × Clear all
NCT01598298 2022-12-16

S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy

SWOG Cancer Research Network

Phase 3 Completed
299 enrolled 10 charts
Breast

Breast Neoplasms, Pain

NCT04732455 2022-07-11

TIPN

Alexandria University

Phase NA Completed
60 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT01912612 2020-08-06

Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain

University of Michigan Rogel Cancer Center

Phase 2 Completed
82 enrolled 26 charts
Breast

Breast Neoplasms, Pain

NCT01028352 2013-08-08

Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain

University of Michigan Rogel Cancer Center

Phase NA Completed
35 enrolled 6 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡